Pfizer and BioNTech could make $13bn from coronavirus vaccine

Johnson& Johnson and AstraZeneca pledged to make their vaccines available on a not-for-profit basisCoronavirus – latest updatesSee all our coronavirus coverageThe US drugmaker Pfizer and the German biotech firm BioNTech stand to bring in nearly $13bn ( £9.8bn) in global sales from theircoronavirus vaccine next year, which will be evenly split between the two companies, according to analysts at the US investment bank Morgan Stanley.Pfizer ’s half would be more than the US pharmaceutical group’s bestselling product, a pneumonia vaccine that generated $5.8bn last year.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Pfizer Pharmaceuticals industry Coronavirus Vaccines and immunisation Business World news Infectious diseases Science Source Type: news